Stock ENBI ENTHEON BIOMEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange
Other stock markets
 10:00:58 2024-12-13 am EST 		5-day change 1st Jan Change
0.1700 CAD 0.00% Intraday chart for Entheon Biomedical Corp. -2.86% +70.00%
Dec. 02 Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding CI
Oct. 24 Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Entheon Biomedical : CFO Certification
22-07-26
 PU
Entheon Biomedical : CEO Certification
22-07-26
 PU
Entheon Biomedical : Quarterly Report
22-07-26
 PU
Entheon Biomedical : CFO Certification
22-03-31
 PU
Entheon Biomedical : CEO Certification
22-03-30
 PU
Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform
22-03-30
 AQ
Entheon Biomedical Announces Participation in the Benzinga Global Small Cap Conference
21-12-03
 NE
BTV Investor Alert Video: Entheon Biomedical Corp. - Treating Addiction
21-11-22
 NE
Microdose Psychedelic Insights Announces Entheon Biomedical, Levitee Labs, and Women in Psychedelics to take centre stage at Psychedelic Capital: September 30, 2021
21-09-23
 NE
Leading DMT Companies to Take Stage at Molecular Masterclass: DMT Conference
21-09-01
 NE
Entheon Biomedical : Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics
21-08-30
 AQ
Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon Advisory Board
21-08-25
 NE
Entheon Biomedical Corp. Announces DTC Eligibility
21-08-24
 NE
Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine
21-08-12
 NE
Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
21-07-30
 NE
Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw
21-07-28
 NE
Microdose Is Pleased to Announce the DMT Conference: A Molecular Masterclass
21-07-27
 NE
Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana
21-06-30
 NE
Entheon Subsidiary, HaluGen Life Sciences, Partners with Maya Health to Drive Psychedelics Genetic Test Kit Awareness
21-06-25
 NE
Entheon Biomedical : Subsidiary HaluGen Life Sciences Announces Agreement with Third Wave
21-06-23
 AQ
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave
21-06-22
 NE
Entheon Biomedical Corp :. Announces Agreement to Acquire Lobo Genetics Inc
21-06-17
 AQ
Entheon Biomedical : Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership
21-06-17
 AQ
Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness Announces Psychedelics Genetic Test Kit Partnership
21-06-17
 NE
Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.
21-06-16
 NE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENBI Stock
  4. News Entheon Biomedical Corp.
  5. Press Releases